Certican 0.25 mg Tablet Certican 0.25 mg Tablet Certican 0.25 mg Tablet Certican 0.25 mg Tablet Certican 0.25 mg Tablet

Certican 0.25 mg Tablet

897.0 INR/Strip

Product Details:

  • Origin of Medicine Switzerland
  • Physical Form Tablets
  • Recommended For DOCTOR
  • Quantity 225 Strip
  • Click to view more
X

Certican 0.25 mg Tablet Price And Quantity

  • 897.0 INR/Strip
  • 225 Box

Certican 0.25 mg Tablet Product Specifications

  • Tablets
  • DOCTOR
  • 225 Strip
  • Switzerland

Certican 0.25 mg Tablet Trade Information

  • 1 Week

Product Description

Certican 0.25 mg tablets contain the active ingredient everolimus, an innovative anticancer therapy designed to combat various advanced cancers, including those of the pancreas, stomach, intestines, and lungs, particularly when surgical options are not viable. This medication is particularly effective for postmenopausal women suffering from advanced hormone receptor-positive and HER2-negative breast cancer, offering a targeted approach to treatment. Additionally, Certican is indicated for adult patients with advanced kidney cancer who have not responded to prior therapies such as sunitinib or sorafenib. By inhibiting specific pathways that promote cancer cell growth, everolimus helps slow tumor progression and improve patient outcomes. It's essential to be aware of potential side effects, including increased risk of infection, as this medication can impact immune function. Patients should consult their healthcare provider for thorough guidance and monitoring while using Certican. With its precise mechanism of action, Certican 0.25 mg tablets represent a crucial option in the ongoing fight against complex cancer types.
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Pharmaceutical Tablets' category



Back to top